Literature DB >> 19290946

The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the field: a preliminary report.

S A Barker1.   

Abstract

Beginning in 2004, the horseracing industry experienced an epidemic of drug positives for the amphetamine-like drug aminorex. Investigation of the therapeutic treatment of the horses called positive for this drug suggested that its source was from the administration of the anthelmintic levamisole. This study examines the urine concentrations of aminorex as a function of time following administration of synthetic, racemic aminorex. Confirmation of the presence of aminorex in urine samples from the horses known to be treated with levamisole is also presented as are data concerning the concentrations of aminorex in positives called from the field and the corresponding concentrations of levamisole found in the same samples. Furthermore, this study illustrates that the chiral isomer distribution of aminorex found in samples from the field is significantly different from that arising from the administration of synthetic, racemic aminorex and is similar to that observed from aminorex arising from levamisole administration. An examination of the chiral isomer distribution of aminorex and a determination of the presence of levamisole in a sample may be used to assess the source of an aminorex positive, distinguishing it from an intentional synthetic, racemic aminorex administration. The role of levamisole in aminorex formation is also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290946     DOI: 10.1111/j.1365-2885.2008.01015.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  6 in total

1.  Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').

Authors:  Simon D Brandt; Michael H Baumann; John S Partilla; Pierce V Kavanagh; John D Power; Brian Talbot; Brendan Twamley; Olivia Mahony; John O'Brien; Simon P Elliott; Roland P Archer; Julian Patrick; Kuldip Singh; Nicola M Dempster; Simon H Cosbey
Journal:  Drug Test Anal       Date:  2014-05-19       Impact factor: 3.345

2.  Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.

Authors:  Jérémy T Campillo; Céline Eiden; Michel Boussinesq; Sébastien D S Pion; Jean-Luc Faillie; Cédric B Chesnais
Journal:  Br J Clin Pharmacol       Date:  2021-09-15       Impact factor: 3.716

Review 3.  Cocaine adulteration.

Authors:  Oliver Kudlacek; Tina Hofmaier; Anton Luf; Felix P Mayer; Thomas Stockner; Constanze Nagy; Marion Holy; Michael Freissmuth; Rainer Schmid; Harald H Sitte
Journal:  J Chem Neuroanat       Date:  2017-06-12       Impact factor: 3.097

Review 4.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

5.  Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.

Authors:  Tina Hofmaier; Anton Luf; Amir Seddik; Thomas Stockner; Marion Holy; Michael Freissmuth; Gerhard F Ecker; Rainer Schmid; Harald H Sitte; Oliver Kudlacek
Journal:  Neurochem Int       Date:  2013-12-01       Impact factor: 4.297

6.  Aminorex identified in horse urine following consumption of Barbarea vulgaris; a preliminary report.

Authors:  George Maylin; Clara Fenger; Jacob Machin; Sucheta Kudrimoti; Rodney Eisenberg; Jonathan Green; Thomas Tobin
Journal:  Ir Vet J       Date:  2019-12-23       Impact factor: 2.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.